This is an information and panel session to highlight the Advanced Research Projects Agency for Health (ARPA-H).
Friday, April 10, from 2:00 pm–3:00 pm; Zoom
Register by Thursday, April 9. The RDO will send a calendar invitation and Zoom link upon registration.
About ARPA-H
"The Advanced Research Projects Agency for Health (ARPA-H) is a research funding agency that supports transformative biomedical and health breakthroughs – ranging from the molecular to the societal – to provide health solutions for all."
Focus Areas:
- Health Science Futures: Expanding what’s technically possible
- Proactive Health: Keeping people from being patients
- Resilient Systems: Building integrated health care systems
- Scalable Solutions: Reaching everyone quickly
Source: ARPA-H
ARPA-H Funding Opportunities
"The ARPA-H funds high-impact, innovative health research focused on solving complex challenges that can significantly improve health outcomes. Using diverse funding mechanisms, ARPA-H can address the critical challenges that traditional research and private industry cannot."
Initiatives and Sprints
Initiatives and Sprints are special efforts designed to rapidly move from proposal to funded contracts. Unlike programs that are driven by a single goal, these targeted investments follow unique funding tracks across a range of topics.
Open Initiatives and Sprints:
- Evidence-Based Validation & Innovation for Rapid Therapeutics in Behavioral Health (EVIDENT): The EVIDENT program, aims to catalyze a new era in behavioral health by generating and validating objective FDA-ready clinical endpoints for emerging therapies, enabling rapid, personalized, and durable improvements in mental and behavioral health. ARPA-H-CXHUB-26-109 and ARPA-H-CXHUB-26-110
Mission Office Innovative Solution Openings (ISO)
ISOs provide a way to seek funds for individual research projects that fall outside the scope of an ARPA-H program or initiative, but that still aligns with an ARPA-H research focus areas.
Open Innovative Solution Openings:
- Health Science Futures Office ISO: Supports research that removes scientific and technological limitations that stymie progress towards the health care of the future. ARPA-H-SOL-24-104
- Proactive Health Office ISO: Supports research that focuses on preventative programs that reduce the likelihood that people become patients. ARPA-H-SOL-24-106
- Resilient Systems Office ISO: Supports research that builds robust and integrated health care systems. ARPA-H-SOL-24-103
- Scalable Solutions Office ISO: Supports research that addresses challenges to geography, distribution, manufacturing, data and information, and economies to promote equitable solutions. ARPA-H-SOL-24-105
Programs
A Program is a collective set of research funded by ARPA-H that focuses on a specific problem or challenge that aligns with the agency’s wider research and development goals.
Open Programs:
- Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE): The ADVOCATE program aims to transform advanced cardiovascular disease management with an agentic AI system that can provide 24/7 holistic clinical care. RPA-H-SOL-26-142
BIOmolecular Grammar for protein Aggregation Modulation and Intervention (BIOGAMI): The BIOGAMI program aims to stop diseases like Alzheimer’s and other brain disorders by finding and fixing problems with proteins very early—before they clump together and damage cells. ARPA-H-SOL-26-149
- BioStabilization Systems (BoSS): The BoSS Program will eliminate deep freeze requirements, paving the way for a new era of efficient and resilient manufacturing and distribution of biologic drugs. ARPA-H-SOL-26-136
- Critical Illness Immunological Reprogramming and Control Point Learning Engine (CIRCLE): The CIRCLE Program will develop new digital twin capabilities to treat critical illness using the latest in AI and diagnostics. ARPA-H-SOL-26-139
Event Information
The Research Development Office is hosting a virtual information and panel session on Friday, April 10, from 2:00 pm–3:00 pm. Join us virtually to learn more about ARPA-H. During the session, the RDO will give an overview of the programs, and two successful awardees will discuss their experiences, share their insights, and respond to your questions.
Panelists
- Karen Dunn Lopez (Professor, Nursing)
- Jill Kolesar (Dean, College of Pharmacy; Jean M. Schmidt Chair and Professor, Drug Discovery)
Registration
Register here by April 9. The RDO will send calendar invitation and Zoom link upon registration.
Questions?
Please email vpr-rdo@uiowa.edu with any questions. Sign up for the RDO Monthly Newsletter to stay up-to-date on RDO activities here!
Sponsored by:
Individuals with disabilities are encouraged to attend all University of Iowa–sponsored events. If you are a person with a disability who requires a reasonable accommodation in order to participate in this program, please contact Research Development Office in advance at 319-335-2119 or vpr-rdo@uiowa.edu.